Cogent Biosciences Inc (COGT) — Cash Flow Reinvestment Rate

Latest as of December 2015: 0.11x

Cogent Biosciences Inc (COGT) has a Cash Flow Reinvestment Rate of 0.11x as of December 2015, reinvesting $1.99 Million (capex $1.99 Million ) from operating cash flow of $17.72 Million. Check COGT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.11x
(Capex + Investments) / Operating CF

Total Reinvested

$1.99 Million
Capex + Investments

Operating Cash Flow

$17.72 Million
USD

Capital Expenditures

$1.99 Million
USD

Cogent Biosciences Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Cogent Biosciences Inc across 1 annual periods. Explore investment intensity of Cogent Biosciences Inc to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Cogent Biosciences Inc (2015–2015)

Year-by-year capital reinvestment analysis for Cogent Biosciences Inc. For live market cap and broader valuation context, see COGT company net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.11x $1.99 Million $17.72 Million $1.99 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow